Literature DB >> 737132

Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis.

M Schmoll, T Henseler, E Christophers.   

Abstract

A total of 90 patients with psoriasis were treated either by photochemotherapy (PUVA) or by topical steroids under occlusion (TOC). In a third group of patients a combination of both regimens was applied. All patients received approximately 15 treatments of either type. During therapy, biopsies were taken in all treatment groups and the epidermal thickness was monitored planimetrically. After clearing of the skin the patients were left without treatment and the time of onset of new lesions was recorded. While TOC produced rapid clearing of the skin this was followed by early relapses (in 50% of the patients after 3 weeks). PUVA reduced psoriatic hyperplasia more slowly; however, 50% of the patients remained free of psoriasis for approximately 10 weeks after clearance. Psoriasis treated with steroids under occlusion together with PUVA showed a significantly faster return of the skin to normal as compared to PUVA. As in PUVA-treated patients relapses occurred after approximately 12 weeks is this group. Therefore the combination of both treatments appears to be advantageous for rapid skin clearance and comparatively long remissions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737132     DOI: 10.1111/j.1365-2133.1978.tb07065.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Therapy of psoriasis with retinoid plus PUVA: clinical and histologic data.

Authors:  G Heidbreder; E Christophers
Journal:  Arch Dermatol Res       Date:  1979-05-04       Impact factor: 3.017

2.  Autoradiographic and planimetric analyses of the inflammatory infiltrate in psoriatic lesions under PUVA-therapy.

Authors:  M Landthaler; G Plewig; C Hofmann; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.